N(G)-nitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: Effect of hypercholesterolemia

Atherosclerosis

Volumn 135, Issue 1, 1997, Pages 49-55

  Brandes, Ralf P ^a   Behra, Andreas ^a   Lebherz, Corinna ^a   Böger, Rainer H ^a   Bode Böger, Stefanie M ^a   Phivthong Ngam, Laddaval ^a   Mügge, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Endothelial derived hyperpolarizing factor; Hypercholesterolemia; N(G) nitro L arginine; Nitric oxide; Renal artery

Indexed keywords

INDOMETACIN; N(G) NITROARGININE;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CHOLESTEROL INTAKE; CONTROLLED STUDY; DEPOLARIZATION; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RENAL ARTERY;

ANIMALS; AORTA, THORACIC; CHOLESTEROL, DIETARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; INDOMETHACIN; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITROARGININE; PROADIFEN; QUATERNARY AMMONIUM COMPOUNDS; RABBITS; RENAL ARTERY;

EID: 0030840255     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00145-7     Document Type: Article

References (34)

1. Moncada S., Herman A.G., Higgs E.A., Vane J.R. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res. 11:1977;323-344.
2. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
3. Taylor S.G., Weston A.H. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. 9:1988;272-274.
4. Cohen R.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization - beyond nitric oxide and cyclic GMP. Circulation. 92:1995;3337-3349.
5. Garland C.J., Plane F., Kemp B.K., Cocks T.M. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 16:1995;23-30.
6. Corriu C., Feletou M., Canet E., Vanhoutte P.M. Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarization in the guinea-pig isolated carotid artery. Br J Pharmacol. 117:1996;607-610.
7. Hecker M., Bara A.T., Bauersachs J., Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome p450-derived arachidonic acid metabolite in mammals. J Physiol (London). 481:1994;407-414.
8. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 78:1996;415-423.
9. Chen G., Suzuki H. Some electrical properties of the endothelium-dependent hyperpolarization recorded from rat arterial smooth muscle cells. J Physiol (London). 410:1989;91-106.
10. Adeagbo A.S.O., Triggle C.R. Varying extracellular K+: a functional approach to seperating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol. 21:1993;423-429.
11. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
12. Mügge A., Brandes R.P., Böger R.H.et al. The vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol. 24:1994;994-998.
13. Najibi S., Cowan C.L., Palacino J.J., Cohen R.A. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol. 266:1994;H2061-H2067.
14. Najibi S., Cohen R.A. Enhanced role of K+ channels in relaxations of hyperhcolesterolemic rabbit carotid artery to NO. Am J Physiol. 269:1995;H805-H811.
15. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.
16. Böger R.H., Bode-Böger S.M., Mügge A.et al. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 117:1995;273-284.
17. Förstermann U., Mügge A., Alheid U., Haverich A., Frölich J.C. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res. 62:1988;185-190.
18. G-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol. 176:1990;219-223.
19. G-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol. 99:1990;408-412.
20. Mügge A., Peterson T., Harrison D.G. Release of nitrogen oxides from cultured bovine aortic endothelial cells is not impaired by calcium channel antagonists. Circulation. 83:1991;1404-1409.
21. Garcia M.L., Knaus H.G., Munojos P., Slaughter R.S., Kaczorowski G.J. Charybdotoxin and its effects on potassium channels. Am J Physiol. 269:1995;C1-C10.
22. Garthwaite J., Southam E., Boultopn C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide.sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol. 48:1995;184-188.
23. Cellek S., Kasakov L., Moncada S. Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase. Br J Pharmacol. 118:1996;137-140.
24. Feletou M., Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 93:1988;515-524.
25. G-nitro-L-arginine in rats. Am J Physiol. 263:1992;H1090-H1094.
26. Cowan C.L., Palacino J.J., Najibi S., Cohen R.A. Potassium channel-mediated relaxation to acetylcholine in rabbit arteries. J Pharm Exp Ther. 266:1993;1482-1489.
27. Kühberger E., Groschner K., Kukovetz W.R., Brunner F. The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery. Br J Pharmacol. 113:1994;1289-1294.
28. Bauersachs J., Hecker M., Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol. 113:1994;1548-1553.
29. Nakashima M., Mombouli J.V., Taylor A.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 92:1993;2867-2871.
30. Mügge A., Lopez J.A.G., Piegors D.J., Breese K.R., Heistad D.D. Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine. Am J Physiol. 260:1991;H242-H247.
31. Verbeuren T.J., Jordaens F.H., Zonnekeyn L.L., Van Hove C.E., Coene M.C., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res. 58:1986;552-564.
32. Bossaller C., Habib G.B., Yamamoto H., Williams C., Wells S., Henry P.D. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′- monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 79:1987;170-174.
33. Chappell S.P., Lewis M.J., Henderson A.H. Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations. Cardiovasc Res. 21:1987;34-38.
34. Jayakody L., Senaratne M., Thomson A., Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res. 60:1987;251-264.